S. Marakatham

Advancing Pharmacovigilance: AI and Deep Learning Approaches to Detect Adverse Drug Reactions from Big Data

The systematic monitoring of post-marketing drug safety is paramount to ensuring patient welfare and population-level health, requiring the timely detection and prevention of adverse drug events. Traditional pharmacovigilance schemes, which largely rely on spontaneous reporting, have weaknesses, including underrepo...